Liantai Pharmaceutical

Liantai Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of high-quality generic and innovative medicines. The company maintains a strong focus on respiratory health, particularly in the development of metered-dose inhalers (MDI) and dry powder inhalers (DPI) for asthma and chronic obstructive pulmonary disease (COPD). Beyond respiratory care, Liantai produces a diverse portfolio of treatments for cardiovascular diseases, digestive disorders, and infectious diseases. With a commitment to international quality standards, the company operates advanced manufacturing facilities in Shenzhen. It aims to expand its presence in both domestic and global markets through strategic partnerships and a robust pipeline of inhalation therapies. The company is recognized for its technical expertise in complex drug-device combination products.